Skip to Main Content

Author Details

James R Bading
City of Hope National Medical Center
1982
63
32
PMIDPaper TitleJournal TitlePublished Year
34857660Use of <sup>64</sup>Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study.J Nucl Med2022
32822229Preclinical PET Imaging of NTSR-1-Positive Tumors with <sup>64</sup>Cu- and <sup>68</sup>Ga-DOTA-Neurotensin Analogs and Therapy with an <sup>225</sup>Ac-DOTA-Neurotensin Analog.Cancer Biother Radiopharm2021
34638132Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma.Blood Adv2021
31910346Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies.Cancer Biother Radiopharm2020
28637802Tumor Uptake of <sup>64</sup>Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.J Nucl Med2018
28450564Diagnostic PET Imaging of Mammary Microcalcifications Using <sup>64</sup>Cu-DOTA-Alendronate in a Rat Model of Breast Cancer.J Nucl Med2017
25879155Adaptations of Arginine's Intestinal-Renal Axis in Cachectic Tumor-Bearing Rats.Nutr Cancer2015
26059190Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.Clin Cancer Res2015
24337604Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.J Nucl Med2014
24312151Tumor quantification in clinical positron emission tomography.Theranostics2013
22294484Kinetic analysis of 18F-FLT PET in lung tumors.J Nucl Med2012
22661534Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner.J Nucl Med2012
21692471In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.Bioconjug Chem2011
20554731Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET.J Nucl Med2010
18158952In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET.Nucl Med Biol2008
18771344Quantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice.Cancer Biother Radiopharm2008
18523066Imaging of cell proliferation: status and prospects.J Nucl Med2008
18687316Changes in regional brain perfusion during functional brain activation: comparison of [(64)Cu]-PTSM with [(14)C]-Iodoantipyrine.Brain Res2008
18312824Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein.Nucl Med Biol2008
17988078A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies.Bioconjug Chem2008
17671224Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.Cancer Res2007
16315003Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide.Mol Imaging Biol2006
16951153Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice.Cancer Res2006
15799827Integrin alpha v beta 3-targeted imaging of lung cancer.Neoplasia2005
16306643Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging.Phys Med Biol2005
15093810Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.Nucl Med Biol2004
15299066microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.J Nucl Med2004
15296674Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide.Mol Imaging2004
15212714Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors.Hum Gene Ther2004
15380745MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.Mol Imaging Biol2004
15377114Accurate estimation of the Fisher information matrix for the PET image reconstruction problem.IEEE Trans Med Imaging2004
15471848Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.J Nucl Med2004
1501348318F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.Nucl Med Biol2004
14741566Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation.Nucl Med Biol2004
14733582MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.Bioconjug Chem2004
15118844MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide.Eur J Nucl Med Mol Imaging2004
12839957Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats.Cancer Res2003
12529925Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.Vascul Pharmacol2002
12164385Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy.J Drug Target2002
12202714Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings.Radiology2002
11696640Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET.J Nucl Med2001
11120756Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.J Clin Invest2000
10938471Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells.Nucl Med Biol2000
10974205Validation of fluorouracil metabolite analysis in excised tumor. Lability of anabolites.Biochem Pharmacol2000
11038003Blocking catabolism with eniluracil enhances PET studies of 5-[18F]fluorouracil pharmacokinetics.J Nucl Med2000
9422364Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy.J Neurochem1998
8622570Evidence of sodium-dependent glucose transport in human erythroleukemia cells.Life Sci1996
8940721System A amino acid transport in cultured human tumor cells: implications for tumor imaging with PET.Nucl Med Biol1996
8940714PET and [18F]-FDG in oncology: a clinical update.Nucl Med Biol1996
7956742Transport limits cellular entry of hepatic arterially injected 5-[18F]fluoro-2'-deoxyuridine in human intrahepatic tumors.Drug Metab Dispos1994
  • 1 - 50 of 63

Recommended Authors

Milan Grkovski
Memorial Sloan Kettering Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Jinxia Guo
Career Start Year 2012
Number of shared co-authors 2
Vincenzo Paolillo
UT MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 1
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 1
Youngho Seo
University of California san francisco
Career Start Year 2005
Number of shared co-authors 2
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 0
Ludwig Dubois
Maastricht University
Career Start Year 2004
Number of shared co-authors 0
Natasja G Lieuwes
Maastricht University
Career Start Year 2003
Number of shared co-authors 0
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 3
Nobuyuki Kosaka
University of Fukui.
Career Start Year 1997
Number of shared co-authors 0
Neeta Pandit-Taskar
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Leo G Flores
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 1
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Juri G Gelovani
Karmanos Cancer Institute (KCI), Wayne State University
Career Start Year 1990
Number of shared co-authors 3
Lixin Lang
First Hospital of Shanxi Medical University, Shanxi Medical University
Career Start Year 1989
Number of shared co-authors 2
Magnus Dahlbom
David Geffen School of Medicine, university of california los angeles
Career Start Year 1988
Number of shared co-authors 5
Johannes Czernin
university of california los angeles
Career Start Year 1987
Number of shared co-authors 2
John J Sunderland
University of Iowa
Career Start Year 1986
Number of shared co-authors 1
John L Humm
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 0
Martin W Brechbiel
National Institutes of Health
Career Start Year 1985
Number of shared co-authors 0
James P Basilion
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 1
Michael J Adam
University of Washington School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Richard L Wahl
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Career Start Year 1983
Number of shared co-authors 1
Dale O Kiesewetter
National Institute of Biomedical Imaging and Bioengineering
Career Start Year 1983
Number of shared co-authors 2
Peter L Choyke
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 1
Jiahe Tian
First Medical Center of Chinese PLA General Hospital
Career Start Year 1982
Number of shared co-authors 1
Chaitanya Divgi
Columbia University Medical Center Kreitchman PET Center
Career Start Year 1981
Number of shared co-authors 0
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1978
Number of shared co-authors 0
Pradeep K Garg
Wake Forest University School of Medicine
Career Start Year 1972
Number of shared co-authors 0

Collaborators

Peter S Conti
Keck School of Medicine of USC
Co-authored papers 29
Xiaoyuan Chen
Institute of Molecular and Cell Biology
Co-authored papers 10
Mian M Alauddin
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Simon R Cherry
University of California Davis Davis
Co-authored papers 2
Richard M Leahy
University of Southern California
Co-authored papers 2
Quanzheng Li
Massachusetts General Hospital
Co-authored papers 1
Evren Asma
General Electric Global Research Center
Co-authored papers 1
Kathleen Nguyen
Co-authored papers 1
Fouad Kandeel
Co-authored papers 1
Scott T Grafton
Co-authored papers 1
Peter W Laird
Van Andel Institute
Co-authored papers 1
Bing Bai
Hefei National Laboratory, University of Science and Technology of China
Co-authored papers 1
Jinyi Qi
University of California davis
Co-authored papers 1
David M Holtzman
Co-authored papers 1
Release 1.2